ISB News

ISBers Doing Cool Things: Consulting on a Commerical Shoot

ISB scientists show actor Joe Flores (foreground) how to pipette.

ISB scientists show actor Joe Flores (foreground) how to pipette.

ISB sometimes gets requests from production crews who need to film in a lab setting. Our labs are so open and beautiful that producers get excited about shooting on site. We worked with crew that was shooting a commercial for a large brokerage firm that featured an actor playing a scientist. Four of our scientists got the opportunity to be extras for the shoot. They also served as consultants, teaching the actor how to pipette and how to handle a beaker. There was much more lighting and camera equipment than any of us expected, but it was a fun bit of chaos for half a day. To see some more photos, visit this page.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.